BCL2L1 and Thrombocytopenia: The straightforward embedding of ABT263 in a VHL-based PROTAC was hypothesized to be effective in BCL-xL-dependent T cell acute lymphoblastic leukemia and T cell lymphoma with minor exploitation of thrombocytopenia, with E3 ligase minimally expressed in platelets [34,35].